Investment thesis
Life science investor making venture, growth, credit and principal investments across the healthcare sector.
Sesamers tracks 5 portfolio companies across 6 rounds, 4 of them as lead investor. Its most recent tracked deal: Commit Biologics, Nov 2026.
Portfolio
CB
Commit Biologics
Seed · 2026 · Copenhagen, Denmark
OMass Therapeutics
Series C · 2026 · Led · Oxford, United Kingdom
A
AnaCardio
Series B · 2026 · Led · Stockholm, Sweden
BT
Breye Therapeutics
Series A · 2026 · Led · Hørsholm, Denmark
Reduced
Series A · 2026 · Led · 2 rounds · Copenhagen, Denmark
Past investments
| Company | Round | Role | Date | Round size |
|---|---|---|---|---|
| Commit Biologics Copenhagen, Denmark | Seed | Participant | Nov 2026 | €54.7M |
| OMass Therapeutics Oxford, United Kingdom | Series C | Lead | Oct 2026 | €276.1M |
| AnaCardio Stockholm, Sweden Read the announcement → | Series B | Lead | Sep 2026 | €62.5M |
| Breye Therapeutics Hørsholm, Denmark Read the announcement → | Series A | Lead | Sep 2026 | €67.5M |
| Reduced Copenhagen, Denmark | Series A | Participant | Feb 2026 | €4M |
| Reduced Copenhagen, Denmark | Seed | Lead | Apr 2024 | €6M |